Press Releases
Image
May 8, 2019
Today, the Ways and Means Committee held a hearing on Paid Family and Medical Leave.
Issues:Health Care
Image
May 2, 2019
Today, the Congressional Joint Strike Fighter (JSF) Caucus Co-Chairs, Reps. John B. Larson (CT-01), Marc A. Veasey (TX-33), Martha Roby (AL-02), and Michael R. Turner (OH-10), shared a letter signed by 128 retired General Officers in support of the F-35 Joint Strike Fighter.
Image
April 22, 2019
Ways and Means Social Security Subcommittee Chairman John B. Larson (CT-01) released the following statement on the 2019 Social Security Trustees Report.
Issues:Social Security
Image
April 18, 2019
Today, Rep. John B. Larson (CT-01) announced the winner of the First Congressional District Art Competition.
Image
April 18, 2019
Today, Rep. John B. Larson (CT-01) released the following statement after Attorney General William Barr’s press conference on Special Counsel Mueller’s report.
Issues:Judicial
Image
April 15, 2019
Over the weekend, Rep. John B. Larson (CT-01), Speaker Nancy Pelosi and other Congressional leaders met with U.S. Commanders in Stuttgart, Germany.
Issues:DefenseForeign Policy
Image
April 10, 2019
Today, Reps. John B. Larson (CT-01) and Kenny Marchant (TX-24) introduced the Invest in America Act that would repeal the Foreign Investment in Real Property Tax Act of 1980, which applies capital gains taxes to foreign persons who invest in U.S. real estate.
Image
April 10, 2019
Today, Chairman John B. Larson (CT-01) held a hearing focused on comprehensive legislative proposals to enhance Social Security, including the Social Security 2100 Act.
Issues:LocalSocial Security
Image
April 10, 2019
Rep. John B. Larson (CT-01) voted in favor of the “Save the Internet Act” (H.R. 1644), which restores strong, commonsense net neutrality protections.
Issues:Technology
Image
April 9, 2019
Today, the Ways and Means Committee marked-up the H.R. 2113, the Prescription Drug Sunshine, Transparency, Accountability and Reporting (STAR) Act, which will require more transparency regarding prescription drug prices.